Amgen (AMGN) EBT Margin (2009 - 2026)

Amgen has reported EBT Margin for 18 years, with the latest figure at 27.53% in Q2 2026.

• On a quarterly basis, EBT Margin rose 1045.0% year-over-year to 27.53% in Q2 2026; TTM through Jun 2026 was 27.0%, a 574.0% increase from a year earlier, with the FY2025 full-year figure at 24.42%, up 1063.0% from the prior year.
• EBT Margin was 27.53% for Q2 2026 at Amgen, up from 24.18% in the prior quarter.
• The five-year high for EBT Margin was 380.83% in Q4 2022, with the low at 0.91% in Q1 2024.
• Average EBT Margin over 5 years is 43.77%, with a median of 24.2% recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: EBT Margin surged 34970 bps in 2022, then plunged 37043 bps in 2023.
• Over 5 years, EBT Margin stood at 380.83% in 2022, then tumbled by 97 bps to 10.4% in 2023, then fell by 17 bps to 8.61% in 2024, then jumped by 78 bps to 15.35% in 2025, then jumped by 79 bps to 27.53% in 2026.
• The last three EBT Margin figures came in at 27.53% (Q2 2026), 24.18% (Q1 2026), and 15.35% (Q4 2025), per Business Quant data.